Combined first trimester screening pairs an 11–13 week ultrasound measuring nuchal translucency with maternal blood markers to estimate the chance of chromosomal conditions. It attracts a Medicare rebate, unlike NIPT, and the ultrasound also checks early anatomy and dating.
Also known as: CFTS, nuchal translucency scan, 12 week scan
Sources
- Royal Australian and New Zealand College of Obstetricians and Gynaecologists (ranzcog.edu.au)
- Medicare Benefits Schedule Online (mbsonline.gov.au)
Last reviewed: 10 September 2026. Written by the Antega Editorial Team. General information only — always follow the advice of your own clinic, doctor or pharmacist.
